Back to Search
Start Over
Notice of Withdrawal: No Incidence of Nephrogenic Systemic Fibrosis after Gadobenate Dimeglumine Administration in Patients Undergoing Dialysis or Those with Severe Chronic Kidney Disease.
- Source :
-
Radiology [Radiology] 2018 Jan; Vol. 286 (1), pp. 113-119. Date of Electronic Publication: 2017 Jul 21. - Publication Year :
- 2018
-
Abstract
- The authors have requested to withdraw this manuscript from publication because the study was not conducted in full accordance with the relevant institutional IRB protocol. <superscript>©</superscript> RSNA, 2018.
- Subjects :
- Adolescent
Adult
Aged
Contrast Media therapeutic use
Female
Humans
Male
Meglumine adverse effects
Meglumine therapeutic use
Middle Aged
Organometallic Compounds therapeutic use
Renal Insufficiency, Chronic diagnostic imaging
Retrospective Studies
Young Adult
Contrast Media adverse effects
Magnetic Resonance Imaging adverse effects
Magnetic Resonance Imaging methods
Magnetic Resonance Imaging statistics & numerical data
Meglumine analogs & derivatives
Nephrogenic Fibrosing Dermopathy chemically induced
Nephrogenic Fibrosing Dermopathy epidemiology
Organometallic Compounds adverse effects
Renal Dialysis statistics & numerical data
Renal Insufficiency, Chronic therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1527-1315
- Volume :
- 286
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Radiology
- Publication Type :
- Academic Journal
- Accession number :
- 28731375
- Full Text :
- https://doi.org/10.1148/radiol.2017170102